X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (455) 455
female (289) 289
male (265) 265
oncology (214) 214
middle aged (212) 212
hematology (211) 211
adult (205) 205
aged (153) 153
cancer (125) 125
treatment outcome (96) 96
adolescent (88) 88
aged, 80 and over (84) 84
mutation (79) 79
child (78) 78
prognosis (77) 77
animals (74) 74
chemotherapy (74) 74
abridged index medicus (70) 70
therapy (67) 67
antineoplastic combined chemotherapy protocols - therapeutic use (66) 66
child, preschool (64) 64
leukemia (61) 61
mice (58) 58
research (57) 57
disease-free survival (55) 55
expression (54) 54
hemic and lymphatic diseases (54) 54
survival (53) 53
risk factors (50) 50
follow-up studies (49) 49
survival rate (48) 48
genetic aspects (45) 45
gene (43) 43
infant (43) 43
risk (43) 43
young adult (42) 42
apoptosis (41) 41
cell biology (41) 41
survival analysis (41) 41
leukemia, lymphocytic, chronic, b-cell - genetics (39) 39
tumors (38) 38
time factors (37) 37
analysis (36) 36
children (36) 36
retrospective studies (36) 36
gene expression profiling (35) 35
remission induction (34) 34
combined modality therapy (32) 32
disease progression (32) 32
medicine, research & experimental (32) 32
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (32) 32
mutations (31) 31
cell line, tumor (30) 30
cells (30) 30
health aspects (30) 30
transplantation, autologous (30) 30
care and treatment (29) 29
multidisciplinary sciences (29) 29
patients (29) 29
activation (28) 28
acute myeloid-leukemia (28) 28
antineoplastic combined chemotherapy protocols - adverse effects (28) 28
disease (27) 27
genes (27) 27
lymphomas (27) 27
gene expression (26) 26
prospective studies (26) 26
immunology (25) 25
neoplasm staging (25) 25
pediatrics (25) 25
recurrence (25) 25
transplantation (25) 25
neoplasms (24) 24
proteins (24) 24
case-control studies (23) 23
cohort studies (23) 23
doxorubicin - administration & dosage (23) 23
immunotherapy (23) 23
leukemia, lymphocytic, chronic, b-cell - drug therapy (23) 23
leukemia, lymphocytic, chronic, b-cell - pathology (23) 23
polymerase chain reaction (23) 23
rituximab (23) 23
clinical trials (22) 22
diagnosis (22) 22
genotype (22) 22
identification (22) 22
mortality (22) 22
phenotype (22) 22
acute lymphoblastic-leukemia (21) 21
bone marrow transplantation (21) 21
chronic lymphocytic leukemia (21) 21
cyclophosphamide - administration & dosage (21) 21
lymphoma (21) 21
biochemistry & molecular biology (20) 20
gene expression regulation, neoplastic (20) 20
gene-expression (20) 20
lymphocytes (20) 20
toxicity (20) 20
antineoplastic agents - therapeutic use (19) 19
bone marrow (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1111 - 1122
Journal Article
Journal Article
Nature chemical biology, ISSN 1552-4469, 2016, Volume 12, Issue 10, pp. 845 - 852
... uptake of hydrocarbon-stapled peptide helices Gregory H Bird1, Emanuele Mazzola2, Kwadwo Opoku-Nsiah1, Margaret A Lammert1, Marina Godes1, Donna S Neuberg2 & Loren D... 
Animals | Hydrocarbons - chemistry | Peptides - metabolism | Peptides - chemistry | Peptides - pharmacokinetics | Hydrocarbons - metabolism | Fibroblasts - cytology | Mice | Hydrocarbons - pharmacokinetics | Fibroblasts - metabolism | Biophysics | Permeability | Peptides | Cells
Journal Article
Nature communications, ISSN 2041-1723, 2017, Volume 8, Issue 1, pp. 2185 - 12
..., Wandi Zhang8, Carrie Cibulskis2, Asaf Zviran1,3, Donna S. Neuberg 9, Dimitri Livitz 2, Ivana Bozic10, Ignaty Leshchiner 2, Gad Getz 2, Jan A. Burger6, Adrian... 
B-CELL LYMPHOMA | TUMOR-MICROENVIRONMENT | MULTIDISCIPLINARY SCIENCES | INITIAL THERAPY | RESISTANCE | CLONAL EVOLUTION | MUTATIONS | SEQUENCING DATA | SINGLE-ARM | GENOME | PROGRESSION | Pyrazoles - therapeutic use | Prognosis | Humans | Middle Aged | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Clonal Evolution - genetics | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Rituximab - therapeutic use | Phospholipase C gamma - genetics | Aged, 80 and over | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Molecular Targeted Therapy - methods | Pyrazoles - pharmacology | Signal Transduction | Clonal Evolution - drug effects | Down-Regulation | Treatment Outcome | Pyrimidines - pharmacology | Disease Progression | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Whole Exome Sequencing | Rituximab - pharmacology | Drug Resistance, Neoplasm - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Agammaglobulinaemia Tyrosine Kinase | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Mutation | Longitudinal Studies | Drug Resistance, Neoplasm - drug effects | Protein-Tyrosine Kinases - antagonists & inhibitors | Lymphocyte receptors | Therapy | Energy metabolism | Chronic lymphatic leukemia | Transcription | Leukemia | Lymphatic leukemia | Metabolism | Drug resistance | Gene expression | Bruton's tyrosine kinase | Signaling | Lymphocytes B | Immunotherapy | Cell cycle | Evolution | Cancer
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 2, pp. 111 - 121
Journal Article
Nature (London), ISSN 1476-4687, 2017, Volume 547, Issue 7662, pp. 217 - 221
Effective anti-tumour immunity in humans has been associated with the presence of T cells directed at cancer neoantigens(1), a class of HLA-bound peptides that... 
IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | CD4(+) T-CELLS | ANTIGENS | CANCER-IMMUNOTHERAPY | SEQUENCING DATA | EXPRESSION | PEPTIDE | PREDICTION | MOLECULES | EPITOPES | Amino Acid Sequence | Antigens, Neoplasm - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Neoplasm Recurrence, Local - prevention & control | Antigens, Neoplasm - immunology | Humans | Cancer Vaccines - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Cancer Vaccines - chemistry | Antigens, Neoplasm - chemistry | Machine Learning | CD4-Positive T-Lymphocytes - immunology | Neoplasm Recurrence, Local - immunology | Cancer Vaccines - immunology | Histocompatibility Antigens Class II - immunology | Melanoma - genetics | Melanoma - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Patient Safety | High-Throughput Nucleotide Sequencing | Mutation | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Precision Medicine - methods | Care and treatment | Methods | Melanoma | Cancer | Peptides | PD-1 protein | CD8 antigen | Vaccination | Lymphocytes T | Vaccines | Tissues | Immunity | Thymus | Lymphocytes | Immunotherapy | Antigens | Feasibility studies | T cell receptors | Gene expression | Patients | Immunological tolerance | CD4 antigen | Studies | Immune checkpoint | Immunogenicity | Cell death | Histocompatibility antigen HLA | Tumors | Apoptosis
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 26, pp. 2496 - 2506
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 26, pp. 2488 - 2498
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 950 - 961
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2017, Volume 358, Issue 6369, pp. 1443 - 1448
Journal Article